Metraipolis › archive › dc_435d4eecc0b9

Comparative Safety of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1-RAs) in Type 2 Diabetes and Chronic Weight Management: A Real-World Data Study — Europe PMC PMID:40947139

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40947139
DOI
10.1002/pds.70214
License (as archived)
solo-consultazione
Archived
2026-11-10T05:40:20.544Z
SHA-256 of the archived text
dcd5571b136edc030b9bea4492d8cfdd8a11067c032dd09fe7bc3f4e359f15d7
Stable URL of this page
https://metraipolis.com/documento/dc_435d4eecc0b9

How to cite

Comparative Safety of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1-RAs) in Type 2 Diabetes and Chronic Weight Management: A Real-World Data Study — Europe PMC PMID:40947139 — Europe PMC (en), https://europepmc.org/article/MED/40947139 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_435d4eecc0b9 (Metraipolis archive dc_435d4eecc0b9, sha256 dcd5571b136edc030b9bea4492d8cfdd8a11067c032dd09fe7bc3f4e359f15d7)
BibTeX
@misc{dc435d4eecc0b9,
  title = {Comparative Safety of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1-RAs) in Type 2 Diabetes and Chronic Weight Management: A Real-World Data Study — Europe PMC PMID:40947139},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40947139},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_435d4eecc0b9; sha256 dcd5571b136edc030b9bea4492d8cfdd8a11067c032dd09fe7bc3f4e359f15d7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40947139. Agents can read the archived copy with the MCP tool read_document.